FDA
-
-
-
-
-
-
-
Artivion completes $135 million acquisition of Endospan
-
-
-
-
-
-
-
Stifel on Artivion Inc. (AORT): NEXUS FDA approval a clear positive
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Artivion Inc. (AORT)
-
-
-
-
-
-
-
Artivion Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Artivion Inc. (AORT)
-
-
-
-
-
-
-
Artivion (AORT) Announces Presentation of Late-Breaking Clinical Data at EACTS
-
-
-
-
-
-
-
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
-
324,877 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

